{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:52:15Z","timestamp":1787028735262,"version":"build-2736575974"},"reference-count":67,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["DK099257"],"award-info":[{"award-number":["DK099257"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["DK117881"],"award-info":[{"award-number":["DK117881"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["DK119973"],"award-info":[{"award-number":["DK119973"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["TR002383"],"award-info":[{"award-number":["TR002383"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["1P30DK120531-01"],"award-info":[{"award-number":["1P30DK120531-01"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005440","name":"Center for Scientific Review","doi-asserted-by":"publisher","award":["DK096990"],"award-info":[{"award-number":["DK096990"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>As diet and lifestyle have changed, fatty liver disease (FLD) has become more and more prevalent. Many genetic risk factors, such as variants of PNPLA3, TM6SF2, GCKR, and MBOAT7, have previously been uncovered via genome wide association studies (GWAS) to be associated with FLD. In 2018, a genetic variant (rs72613567, T &gt; TA) of hydroxysteroid 17-\u03b2 dehydrogenase family 13 (HSD17B13) was first associated with a lower risk of developing alcoholic liver disease and non-alcoholic fatty liver disease (NAFLD) in minor allele carriers. Other HSD17B13 variants were also later linked with either lower inflammation scores among NAFLD patients or protection against NAFLD (rs6834314, A &gt; G and rs9992651, G &gt; A) respectively. HSD17B13 is a lipid droplet-associated protein, but its function is still ambiguous. Compared to the other genetic variants that increase risk for FLD, HSD17B13 variants serve a protective role, making this gene a potential therapeutic target. However, the mechanism by which these variants reduce the risk of developing FLD is still unclear. Because studies in cell lines and mouse models have produced conflicting results, human liver tissue modeling using induced pluripotent stem cells may be the best way to move forward and solve this mystery.<\/jats:p>","DOI":"10.3390\/jpm11070619","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T03:53:15Z","timestamp":1625025195000},"page":"619","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target"],"prefix":"10.3390","volume":"11","author":[{"given":"Takashi","family":"Motomura","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5434-8745","authenticated-orcid":false,"given":"Sriram","family":"Amirneni","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Diaz-Aragon","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanuza","family":"Faccioli","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Malizio","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Coard","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4156-7647","authenticated-orcid":false,"given":"Zehra","family":"Kocas-Kilicarslan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Frau","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8149-4011","authenticated-orcid":false,"given":"Nils","family":"Haep","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Ostrowska","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"},{"name":"Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Florentino","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Soto-Gutierrez","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA"},{"name":"Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15261, USA"},{"name":"McGowan Institute for Regenerative Medicine, Pittsburgh, PA 15219, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.3748\/wjg.v25.i29.3929","article-title":"Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?","volume":"25","author":"Meringer","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41422-020-00457-7","article-title":"Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients","volume":"31","author":"Chen","year":"2021","journal-title":"Cell Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2018). EASL Recommendations on Treatment of Hepatitis C 2018. J. Hepatol., 69, 461\u2013511.","DOI":"10.1016\/j.jhep.2018.03.026"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhep.2018.09.018","article-title":"Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir\/sofosbuvir in hepatitis C genotype 2 and 3","volume":"70","author":"Belperio","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S2468-1253(20)30249-1","article-title":"Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: A systematic review and meta-analysis","volume":"5","author":"Tseng","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/jso.26433","article-title":"Postoperative imaging surveillance for hepatocellular carcinoma: How much is enough?","volume":"123","author":"Mirdad","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/liv.14430","article-title":"Redefining fatty liver disease classification in 2020","volume":"40","author":"Valenti","year":"2020","journal-title":"Liver Int."},{"key":"ref_9","first-page":"434","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/liv.13185","article-title":"Nonalcoholic fatty liver disease: Cause or consequence of type 2 diabetes?","volume":"36","author":"Valenti","year":"2016","journal-title":"Liver Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Crespo, G. (2021). Moving Forward in the Stratification of Cardiac Risk in Liver Transplantation Candidates. Liver Transplant.","DOI":"10.1002\/lt.26005"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yen, Y.-H., Cheng, Y.-F., Wang, J.-H., Lin, C.-C., and Wang, C.-C. (2021). Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0244939"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbalip.2013.12.006","article-title":"Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function","volume":"1841","author":"Pingitore","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1038\/s41598-019-47737-w","article-title":"The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids","volume":"9","author":"Prill","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Speliotes, E.K., Yerges-Armstrong, L.M., Wu, L., Hernaez, R., Kim, L.J., Palmer, C.D., Gudnason, V., Eiriksdottir, G., Garcia, M.E., and Launer, L.J. (2011). Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet., 7.","DOI":"10.1371\/journal.pgen.1001324"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MOL.0000000000000155","article-title":"Glucokinase regulatory protein: Complexity at the crossroads of triglyceride and glucose metabolism","volume":"26","author":"Raimondo","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gutjnl-2020-320853","article-title":"Loss of hepatic Mboat7 leads to liver fibrosis","volume":"70","author":"Thangapandi","year":"2021","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.970","article-title":"Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma","volume":"43","author":"Chambers","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A Protein-TruncatingHSD17B13Variant and Protection from Chronic Liver Disease","volume":"378","author":"Cheng","year":"2018","journal-title":"New Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort","volume":"73","author":"Anstee","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.30350","article-title":"17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease","volume":"69","author":"Ma","year":"2019","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mce.2018.11.012","article-title":"17B-hydroxysteroid dehydrogenases as acyl thioester metabolizing enzymes","volume":"489","author":"Hiltunen","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mce.2005.11.031","article-title":"Multifunctionality of human 17\u03b2-hydroxysteroid dehydrogenases","volume":"248","author":"Moeller","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.jbchem.a022211","article-title":"Identification of a Principal mRNA Species for Human 3\u03b1-Hydroxysteroid Dehydrogenase Isoform (AKR1C3) That Exhibits High Prostaglandin D2 11-Ketoreductase Activity","volume":"124","author":"Matsuura","year":"1998","journal-title":"J. Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.18388\/abp.2007_3289","article-title":"Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase\/reductase 9","volume":"54","author":"Liu","year":"2007","journal-title":"Acta Biochim. Pol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2008.03.063","article-title":"17beta-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein","volume":"370","author":"Horiguchi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11437","DOI":"10.1073\/pnas.1410741111","article-title":"Comparative proteomic study reveals 17\u03b2-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease","volume":"111","author":"Su","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","first-page":"E357","article-title":"Liver X receptor \u03b1 induces 17\u03b2-hydroxysteroid dehydrogenase-13 expression through SREBP-1c","volume":"312","author":"Su","year":"2017","journal-title":"Am. J. Physiol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Namjou, B., Network, T.E., Lingren, T., Huang, Y., Parameswaran, S., Cobb, B.L., Stanaway, I.B., Connolly, J.J., Mentch, F.D., and Benoit, B. (2019). GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. BMC Med., 17.","DOI":"10.1186\/s12916-019-1364-z"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gtc.2019.09.001","article-title":"Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis","volume":"49","author":"Kozlitina","year":"2020","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/apt.15738","article-title":"Review article: The emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis","volume":"51","author":"Carlsson","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1194\/jlr.P089953","article-title":"Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease","volume":"60","author":"Pirola","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/liv.14387","article-title":"Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in Hispanics\/Latinos","volume":"40","author":"Kallwitz","year":"2020","journal-title":"Liver Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/liv.14495","article-title":"Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease","volume":"40","author":"Seko","year":"2020","journal-title":"Liver Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/liv.14616","article-title":"Genetic variant rs72613567 ofHSD17B13gene reduces alcohol-related liver disease risk in Chinese Han population","volume":"40","author":"Chen","year":"2020","journal-title":"Liver Int."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Raja, A.M., Ciociola, E., Ahmad, I.N., Dar, F.S., Naqvi, S.M.S., Moaeen-Ud-Din, M., Raja, G.K., Romeo, S., and Mancina, R.M. (2020). Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103558"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Anderson, E.L., Howe, L.D., Jones, H.E., Higgins, J., Lawlor, D.A., and Fraser, A. (2015). The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140908"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MPG.0000000000002573","article-title":"The rs72613567:TA Variant in the Hydroxysteroid 17-beta Dehydrogenase 13 Gene Reduces Liver Damage in Obese Children","volume":"70","author":"Umano","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMc1804638","article-title":"HCV-Associated Liver Fibrosis and HSD17B13","volume":"379","author":"About","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/hep.30623","article-title":"A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects from Hepatocellular Carcinoma Development in Alcoholic Liver Disease","volume":"70","author":"Yang","year":"2019","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Enomoto, H., Aizawa, N., Hasegawa, K., Ikeda, N., Sakai, Y., Yoh, K., Takata, R., Yuri, Y., Kishino, K., and Shimono, Y. (2020). Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093089"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Fukuhara, T., Wada, M., Nakamura, S., Ono, C., Shiokawa, M., Yamamoto, S., Motomura, T., Okamoto, T., Okuzaki, D., and Yamamoto, M. (2014). Amphipathic \u03b1-Helices in Apolipoproteins Are Crucial to the Formation of Infectious Hepatitis C Virus Particles. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004534"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.30799","article-title":"High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant","volume":"71","author":"Nordestgaard","year":"2020","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.30996","article-title":"Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers","volume":"72","author":"Stickel","year":"2020","journal-title":"Hepatology"},{"key":"ref_51","first-page":"4216451","article-title":"Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients","volume":"2020","author":"Bellan","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_52","first-page":"1586","article-title":"Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.hbpd.2018.04.006","article-title":"17-beta-hydroxysteroid dehydrogenase 13 inhibits the progression and recurrence of hepatocellular carcinoma","volume":"17","author":"Chen","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cpt.798","article-title":"Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals with Type 2 Diabetes","volume":"103","author":"Rotroff","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_55","first-page":"430","article-title":"Mendelian randomization estimates of alanine aminotransferase with cardiovascular disease: Guangzhou Biobank Cohort study","volume":"26","author":"Xu","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3748\/wjg.v26.i36.5474","article-title":"Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant","volume":"26","author":"Umano","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/j.gastro.2009.04.052","article-title":"Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients without Advanced Disease","volume":"137","author":"Mathurin","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","article-title":"Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro","volume":"57","author":"Pirazzi","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/hep.31517","article-title":"17-Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice from Obesogenic Diet Injury","volume":"73","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene Editing ofCCR5in Autologous CD4 T Cells of Persons Infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ymthe.2019.01.014","article-title":"Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jhep.2016.12.017","article-title":"Host conditioning and rejection monitoring in hepatocyte transplantation in humans","volume":"66","author":"Soltys","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"107711","DOI":"10.1016\/j.celrep.2020.107711","article-title":"Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells","volume":"31","author":"Takeishi","year":"2020","journal-title":"Cell Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cmet.2019.06.017","article-title":"Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism","volume":"30","author":"Takeishi","year":"2019","journal-title":"Cell Metab."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/7\/619\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:23:38Z","timestamp":1760163818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/7\/619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["jpm11070619"],"URL":"https:\/\/doi.org\/10.3390\/jpm11070619","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]}}}